INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,430 Cr | ₹2,178 Cr | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr |
What is the latest Total Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,430 Cr |
| Mar2024 | ₹2,178 Cr |
| Mar2023 | ₹1,714 Cr |
| Mar2022 | ₹1,579 Cr |
| Mar2021 | ₹1,334 Cr |
How is Total Liabilities of INDOCO REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,430 Cr | 11.59 | |
| Mar2024 | ₹2,178 Cr | 27.03 | |
| Mar2023 | ₹1,714 Cr | 8.55 | |
| Mar2022 | ₹1,579 Cr | 18.37 | |
| Mar2021 | ₹1,334 Cr | - | |
Compare Total Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,072.2 Cr | -3% | -8% | -32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -3% |
-8% |
-32.7% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses